Orgil Sedvanchig
Director
Orgil Sedvanchig is a Director at Lazard's Healthcare Group in London where he focuses on clients in the Life Sciences sector.
Orgil advises on a broad range of financial advisory transactions for pharmaceutical, biotech, diagnostic and life science services sectors with transaction experience covering a wide range of strategic assignments including mergers and acquisitions, divestitures, capital raising and restructuring transactions.
Prior to joining Lazard, Orgil was a Director at Moelis & Company in New York and London and started his career at the Central Bank of Mongolia as an investment officer.
Orgil holds an MBA with Dean’s Honors from Columbia University and B.Sc in Finance from the Kelley School of Business.
Our offices in the United Kingdom
Lazard's first London office opened in 1877 on Old Broad Street, near the Bank of England and London's historic stock exchange, placing the firm's U.K. home at the meeting point of British capital, international trade, and the flows of finance.
The U.K. remains one of the largest operations in Lazard's global network, working closely with the firm's teams across continental Europe and the U.S., and in 2025 the firm moved its U.K. headquarters to 20 Manchester Square.
London continues to offer a single, integrated market where sovereign capital, listed companies, and global investors can flourish. From here, Lazard advises clients on a full range of strategic matters including mergers and acquisitions, restructuring and liability management, debt and capital structure, and capital raising. More than 175 years after the firm's founding, Lazard's client relationships in the U.K. still rest on a foundation of independent advice, discretion, and long-standing trust.